Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A randomized, double‐blind, placebo‐controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
Alice B. Gottlieb, Richard Langley, Bruce Strober, et al.
British Journal of Dermatology (2012) Vol. 167, Iss. 3, pp. 649-657
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Alan Menter, Bruce Strober, Daniel H. Kaplan, et al.
Journal of the American Academy of Dermatology (2019) Vol. 80, Iss. 4, pp. 1029-1072
Closed Access | Times Cited: 740
The Inflammatory Response in Psoriasis: a Comprehensive Review
Yaxiong Deng, Christopher Chang, Qianjin Lu
Clinical Reviews in Allergy & Immunology (2016) Vol. 50, Iss. 3, pp. 377-389
Closed Access | Times Cited: 358
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2017)
Open Access | Times Cited: 301
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
Alan Menter, Joel M. Gelfand, Cody Connor, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 6, pp. 1445-1486
Open Access | Times Cited: 258
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Siddharth Singh, Antonio Facciorusso, Abha G. Singh, et al.
PLoS ONE (2018) Vol. 13, Iss. 5, pp. e0195123-e0195123
Open Access | Times Cited: 236
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial
Philip J. Mease, Dafna D. Gladman, David H. Collier, et al.
Arthritis & Rheumatology (2019) Vol. 71, Iss. 7, pp. 1112-1124
Open Access | Times Cited: 191
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2020)
Open Access | Times Cited: 164
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2021) Vol. 2021, Iss. 12
Open Access | Times Cited: 135
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 109
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 92
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Laura C. Coates, Oliver FitzGerald, Philip Helliwell, et al.
Seminars in Arthritis and Rheumatism (2016) Vol. 46, Iss. 3, pp. 291-304
Open Access | Times Cited: 146
Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
Alexander Nast, Anja Jacobs, Stefanie Rosumeck, et al.
Journal of Investigative Dermatology (2015) Vol. 135, Iss. 11, pp. 2641-2648
Open Access | Times Cited: 124
Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials
Richard Conway, Candice Low, Robert J. Coughlan, et al.
BMJ (2015) Vol. 350, Iss. mar13 17, pp. h1269-h1269
Open Access | Times Cited: 118
Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento
L. Puig, J.M. Carrascosa, G. Carretero, et al.
Actas Dermo-Sifiliográficas (2013) Vol. 104, Iss. 8, pp. 694-709
Open Access | Times Cited: 106
Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials
Richard Conway, Candice Low, Robert J. Coughlan, et al.
Seminars in Arthritis and Rheumatism (2015) Vol. 45, Iss. 2, pp. 156-162
Closed Access | Times Cited: 99
Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases
Lesley J. Scott
Drugs (2014) Vol. 74, Iss. 12, pp. 1379-1410
Closed Access | Times Cited: 99
Drug survival of biologic treatments in psoriasis: a systematic review
Daniel J. No, Megan S. Inkeles, Mina Amin, et al.
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 5, pp. 460-466
Closed Access | Times Cited: 86
Systemic methotrexate therapy for psoriasis: past, present and future
Sunil Dogra, Rahul Mahajan
Clinical and Experimental Dermatology (2013) Vol. 38, Iss. 6, pp. 573-588
Closed Access | Times Cited: 80
Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature
Frank Behrens, Juan D. Cañete, Ignazio Olivieri, et al.
Lara D. Veeken (2014) Vol. 54, Iss. 5, pp. 915-926
Open Access | Times Cited: 75
Japanese guidance for use of biologics for psoriasis (the 2019 version)
Hidehisa Saeki, Tadashi Terui, Akimichi Morita, et al.
The Journal of Dermatology (2020) Vol. 47, Iss. 3, pp. 201-222
Open Access | Times Cited: 69
Biologic fatigue in psoriasis
Ethan Levin, Rishu Gupta, Gabrielle Brown, et al.
Journal of Dermatological Treatment (2013) Vol. 25, Iss. 1, pp. 78-82
Closed Access | Times Cited: 70
Which Antipsoriatic Drug Has the Fastest Onset of Action?—Systematic Review on the Rapidity of the Onset of Action
Alexander Nast, Birte Sporbeck, Stefanie Rosumeck, et al.
Journal of Investigative Dermatology (2013) Vol. 133, Iss. 8, pp. 1963-1970
Open Access | Times Cited: 65
Combining Biologic Therapies With Other Systemic Treatments in Psoriasis
April W. Armstrong, Jerry Bagel, Abby S. Van Voorhees, et al.
JAMA Dermatology (2014) Vol. 151, Iss. 4, pp. 432-432
Closed Access | Times Cited: 62
The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions
Lily Adelzadeh, N. Jourabchi, Jashin J. Wu
Journal of the European Academy of Dermatology and Venereology (2013) Vol. 28, Iss. 7, pp. 846-852
Closed Access | Times Cited: 61
Spanish Evidence-Based Guidelines on the Treatment of Psoriasis With Biologic Agents, 2013. Part 1: On Efficacy and Choice of Treatment
L. Puig, J.M. Carrascosa, G. Carretero, et al.
Actas Dermo-Sifiliográficas (2013) Vol. 104, Iss. 8, pp. 694-709
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top